The effect of vehicle on the oral absorption of cyclosporin. 1986

A Johnston, and J T Marsden, and K K Hla, and J A Henry, and D W Holt

Twelve healthy volunteers received four separate doses of cyclosporin (5 mg kg-1). On three occasions the neat oil suspension (Sandimmun) was given dispersed in a different liquid vehicle and on one occasion the suspension was taken directly. Measurement of whole blood cyclosporin concentrations by radioimmunoassay showed no significant difference in the pharmacokinetic parameters of absorption between the neat preparation and the three dispersants used (milk, milk + chocolate flavouring and orange juice).

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003524 Cyclosporins A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Cyclosporines
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001628 Beverages Liquids that are suitable for drinking. (From Merriam Webster Collegiate Dictionary, 10th ed) Beverage
D014677 Pharmaceutical Vehicles A carrier or inert medium used as a solvent (or diluent) in which the medicinally active agent is formulated and or administered. (Dictionary of Pharmacy, 1986) Pharmaceutical Vehicle,Vehicle, Pharmaceutical,Vehicles, Pharmaceutical

Related Publications

A Johnston, and J T Marsden, and K K Hla, and J A Henry, and D W Holt
July 1997, The Journal of pharmacy and pharmacology,
A Johnston, and J T Marsden, and K K Hla, and J A Henry, and D W Holt
October 1981, Journal of pharmaceutical sciences,
A Johnston, and J T Marsden, and K K Hla, and J A Henry, and D W Holt
July 1992, British journal of clinical pharmacology,
A Johnston, and J T Marsden, and K K Hla, and J A Henry, and D W Holt
February 1989, Transplantation proceedings,
A Johnston, and J T Marsden, and K K Hla, and J A Henry, and D W Holt
March 2002, Biopharmaceutics & drug disposition,
A Johnston, and J T Marsden, and K K Hla, and J A Henry, and D W Holt
January 2022, International journal of nanomedicine,
A Johnston, and J T Marsden, and K K Hla, and J A Henry, and D W Holt
June 1999, International journal of pharmaceutics,
A Johnston, and J T Marsden, and K K Hla, and J A Henry, and D W Holt
May 1988, British journal of clinical pharmacology,
A Johnston, and J T Marsden, and K K Hla, and J A Henry, and D W Holt
April 1971, Journal of pharmaceutical sciences,
A Johnston, and J T Marsden, and K K Hla, and J A Henry, and D W Holt
January 2001, Clinical pharmacokinetics,
Copied contents to your clipboard!